Insider Transactions in Q3 2021 at Jazz Pharmaceuticals PLC (JAZZ)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 08
2021
|
Finbar Larkin SVP, Technical Operations |
SELL
Open market or private sale
|
Direct |
63
-0.38%
|
$8,442
$134.51 P/Share
|
|
Sep 01
2021
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
500
-0.16%
|
$65,500
$131.58 P/Share
|
|
Aug 18
2021
|
Patrick G Enright Director |
BUY
Grant, award, or other acquisition
|
Indirect |
2,000
+50.0%
|
$274,000
$137.75 P/Share
|
|
Aug 06
2021
|
Patricia Carr SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
157
-2.54%
|
$23,079
$147.96 P/Share
|
|
Aug 06
2021
|
Peter Gray Director |
SELL
Open market or private sale
|
Direct |
1,414
-9.91%
|
$207,858
$147.96 P/Share
|
|
Aug 06
2021
|
Heather Ann Mc Sharry Director |
SELL
Open market or private sale
|
Direct |
1,414
-11.24%
|
$207,858
$147.96 P/Share
|
|
Aug 06
2021
|
Kenneth W O'Keefe Director |
SELL
Open market or private sale
|
Direct |
1,306
-6.24%
|
$191,982
$147.96 P/Share
|
|
Aug 06
2021
|
Norbert G Riedel Director |
SELL
Open market or private sale
|
Direct |
1,306
-11.16%
|
$191,982
$147.96 P/Share
|
|
Aug 06
2021
|
Catherine A. Sohn Director |
SELL
Open market or private sale
|
Direct |
1,306
-10.15%
|
$191,982
$147.96 P/Share
|
|
Aug 06
2021
|
Rick E Winningham Director |
SELL
Open market or private sale
|
Direct |
1,306
-15.47%
|
$191,982
$147.96 P/Share
|
|
Aug 05
2021
|
Bruce C Cozadd Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,652
+0.85%
|
$121,992
$46.83 P/Share
|
|
Aug 05
2021
|
Neena M Patil EVP & Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
993
-3.79%
|
$146,964
$148.49 P/Share
|
|
Aug 05
2021
|
Paul L Berns Director |
SELL
Open market or private sale
|
Direct |
1,450
-14.89%
|
$223,300
$154.0 P/Share
|
|
Aug 05
2021
|
Elmar Schnee Director |
SELL
Open market or private sale
|
Direct |
1,632
-16.48%
|
$251,328
$154.0 P/Share
|
|
Aug 02
2021
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
1,750
-0.28%
|
$295,750
$169.99 P/Share
|
|
Jul 29
2021
|
Jennifer E. Cook Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,246
+31.71%
|
-
|
|
Jul 29
2021
|
Patrick G Enright Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,246
+9.03%
|
-
|
|
Jul 29
2021
|
Peter Gray Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,246
+13.6%
|
-
|
|
Jul 29
2021
|
Heather Ann Mc Sharry Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,246
+15.15%
|
-
|
|
Jul 29
2021
|
Seamus Mulligan Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,246
+0.19%
|
-
|
|
Jul 29
2021
|
Kenneth W O'Keefe Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,246
+9.7%
|
-
|
|
Jul 29
2021
|
Anne O Riordan Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,246
+18.78%
|
-
|
|
Jul 29
2021
|
Norbert G Riedel Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,246
+16.1%
|
-
|
|
Jul 29
2021
|
Mark Douglas Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,246
+31.71%
|
-
|
|
Jul 29
2021
|
Catherine A. Sohn Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,246
+14.86%
|
-
|
|
Jul 29
2021
|
Rick E Winningham Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,246
+21.01%
|
-
|
|
Jul 01
2021
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
10,850
-3.39%
|
$1,953,000
$180.67 P/Share
|